1993
DOI: 10.1016/s0002-9394(14)73653-0
|View full text |Cite
|
Sign up to set email alerts
|

Blood Dyscrasias and Topical Ophthalmic Chloramphenicol

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
22
0

Year Published

1994
1994
2021
2021

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 49 publications
(23 citation statements)
references
References 3 publications
1
22
0
Order By: Relevance
“…Respondents to our survey indicated that they used several antibiotics that could be problematic from a public health perspective. For instance, the U.S. Food and Drug Administration has prohibited use of chloramphenicol in food animals (DHHS, 2010a) in part because residues in meat products can cause aplastic anemia and other blood disorders in humans (Fraunfelder et al, 1993;Young and Alter, 1994). Consequently, this practice represents a genuine public health risk beyond selecting for antibiotic resistant bacteria and it will certainly contribute to trade complications.…”
Section: Discussionmentioning
confidence: 99%
“…Respondents to our survey indicated that they used several antibiotics that could be problematic from a public health perspective. For instance, the U.S. Food and Drug Administration has prohibited use of chloramphenicol in food animals (DHHS, 2010a) in part because residues in meat products can cause aplastic anemia and other blood disorders in humans (Fraunfelder et al, 1993;Young and Alter, 1994). Consequently, this practice represents a genuine public health risk beyond selecting for antibiotic resistant bacteria and it will certainly contribute to trade complications.…”
Section: Discussionmentioning
confidence: 99%
“…In view of its bone marrow toxicity potential, the use of chloramphenicol in infants is controversial [29]. Subjecting infants to the risks of chloramphenicol cannot be justified while safer alternative anti-infectives are available to treat eye infections [30].…”
Section: Discussionmentioning
confidence: 99%
“…Although it is uncommon to associate the topical ocular use of a medication with adverse systemic effects, such effects are known to occur and are well documented for drugs such as topical beta-blockers, carbonic anhydrase inhibitors, and chloramphenicol 10,11 . Topically applied ophthalmic medications can enter the systemic circulation either via direct absorption through the conjunctiva or through the nasal mucosa following drainage through the lachrymal ducts.…”
Section: Introductionmentioning
confidence: 99%